Future Health Pharma GmbH represents European, US and Chinese companies adhering to the highest ethical principles and having irreproachable research and manufacturing records. We register, distribute and market their products in Switzerland and in countries of the European Union. Future Health Pharma GmbH is either your Marketing Authorisation Holder or establishes your affiliate in Switzerland or in the EU. Future Health Pharma GmbH is also holder of an establishment license to handle controlled substances (narcotics).
15 Rx products at Future Health Pharma GmbH (CH)
Aldomet®, Azzalure®, Combizym®, Dulcolax® Macrogol, Dysport®, Hexvix®, Indocid®-Retard, Kytril®, Miacalcic®, Rasilez®, Somatuline Autogel®, Synacthen®, Synacthen® Depot, Tiamdra® (Co-marketing of Parlodel®), Varidoid® (Co-marketing of Hirudoid®)
3 products have been transferred to a client company and are still cared for by our team.
Origin of information and copyright
© Five Office Ltd, Logos of Science, 2007
Last update: March 2017